The Effects of Hantaan Virus on the Expression of Platelet Activating Factor Receptor and on the Activity of Platelet Activating Factor Acetylhydrolase.
10.12701/yujm.2008.25.1.41
- Author:
Ji Young HWANG
;
Jong Won PARK
;
Sae Yong HONG
;
Ho Sun PARK
- Publication Type:Original Article
- Keywords:
HFRS;
Platelet activating factor;
PAF receptor;
PAF-acetylhydrolase
- MeSH:
Blood Platelets;
Blotting, Western;
Capillary Permeability;
Cardiac Output;
Endothelial Cells;
Endothelium;
Hantaan virus;
Hemorrhage;
Hemorrhagic Fever with Renal Syndrome;
Human Umbilical Vein Endothelial Cells;
Humans;
Hypotension;
Leukocytes;
Plasma;
Platelet Activating Factor;
Platelet Membrane Glycoproteins;
Polymerase Chain Reaction;
Receptors, G-Protein-Coupled;
RNA, Messenger;
Shock
- From:Yeungnam University Journal of Medicine
2008;25(1):41-49
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The central physiological derangement of hemorrhagic fever with renal syndrome (HFRS) caused by hantaan virus (HTNV) is a vascular dysfunction, manifested by hemorrhage, impaired vascular tone and increased vascular permeability. Platelet activating factor (PAF), whose actions are mediated through a specific receptor, is a potent bioactive lipid. PAF has diverse biological functions in the vascular system, such as increasing vascular permeability, adhesion of leukocytes to the endothelium and reduction of cardiac output, which result in hypotension and shock. The goal of the present study was to investigate whether PAF is involved in the pathogenesis of HFRS. For this purpose, we evaluated the effect of HTNV on the expression of PAF receptor (PAF-R) and on the activity of PAF-acetylhydrolase (PAF-AH) instead of PAF because PAF is rapidly degraded by PAF-AH in vivo. MATERIALS AND METHODS: To evaluate the expression of PAF-R, we performed reverse-transcription PCR, western blot and FACS analyses using HTNV-infected human umbilical vein endothelial cells (HUVECs) and non-infected (control) HUVECs. In addition, we measured the activity of plasma PAF-AH in HFRS patients and normal healthy persons. RESULTS: The mRNA and protein expression of PAF-R was increased in HTNV-infected HUVECs compared with control HUVECs at 2 and 3 days post-infection (d.p.i.). FACS analysis showed that HTNV induced the surface expression of PAF-R in HUVECs from 2 d.p.i. The activity of plasma PAF-AH was 2.5-fold lower in HFRS patients than in normal healthy persons. CONCLUSION: Increased PAF-R expression by HTNV might increase the responsiveness to PAF in endothelial cells. Reduced PAF-AH activity in the blood of HFRS patients might delay PAF degradation. These results suggest that changes in PAF-R and PAF-AH by HTNV might influence to PAF activity and might be involved in the vascular dysfunction of HFRS.
